2014 ICD-10 Cause of Death Casefinding List

These tables are also available in a printable version (PDF).

COMPREHENSIVE ICD-10* Casefinding Code List for Reportable Tumors (EFFECTIVE DATES: 1/1/2014-12/31/2014) Please refer to your standard setter(s) for specific reporting requirements before using the Casefinding List
ICD-10 Code Explanation of ICD-10 Code
B21._ Human Immunodeficiency virus [HIV] disease with malignant neoplasms
C00._ – C97._ Malignant neoplasms
Note: Pilocytic/juvenile astrocytoma M-9421 moved from behavior /3 (malignant) to /1 (borderline malignancy) in ICD-O-3. However, SEER registries will CONTINUE to report these cases and code behavior as /3 (malignant).
D00._ – D09._ In-situ neoplasms
Note: Carcinoma in situ of the cervix (CIN III-8077/2) and Prostatic Intraepithelial Carcinoma (PIN III-8148/2) are not reportable.
D18.0 Hemangioma, any site
Note: Includes Hemangiomas of Brain, Other parts of nervous system and endocrine glands, which are reportable.
D18.1 Lymphangioma, any site
Note: Includes Lymphangiomas of Brain, Other parts of nervous system and endocrine glands, which are reportable.
D32._ Benign neoplasm of meninges (cerebral, spinal and unspecified)
D33._ Benign neoplasm of brain and other parts of central nervous system
D35.2 Benign neoplasm of pituitary gland
D35.3 Benign neoplasm of craniopharyngeal duct
D35.4 Benign neoplasm of pineal gland
D42._ Neoplasm of uncertain or unknown behavior of meninges
D43._ Neoplasm of uncertain or unknown behavior of brain and central nervous system
D44.3 – D44.5 Neoplasm of uncertain or unknown behavior of pituitary gland, craniopharyngeal duct and pineal gland
D45 Polycythemia vera (9950/3)
D46._ Myelodysplastic syndromes (9980, 9982, 9983, 9985, 9986, 9989, 9991, 9992)
D47.1 Chronic myeloproliferative disease (9960/3, 9961/3, 9963/3)
D47.3 Esssential (hemorrhagic) thrombocythemia (9962/3)
D47.7 Other specified neoplasms of uncertain/unknown behavior of lymphoid, hematopoietic (9965/3, 9966/3, 9967/3, 9971/3, 9975/3, 9987/3)
D47.9 Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified (9960/3, 9961/3, 9970/1, 9931/3)
D48.9 Neoplasm of uncertain or unknown behavior, unspecified
Note: Review code for uncertain behavior brain, CNS tumors and reportable benign endocrine glands

NOTE: Cases with these codes should be screened as registry time allows. Experience in the SEER registries has shown that using the supplemental list increases casefinding for benign brain and CNS, hematopoietic neoplasms, and other reportable diseases.

SUPPLEMENTAL LIST ICD-10 (EFFECTIVE DATES: 1/1/2014-12/31/2014)
ICD-10 Code* Explanation of ICD-10 Code*
B20._, B22 – B24 Human immunodeficiency virus [HIV] disease with other diseases
Note: Excludes HIV with malignancy (B21), see reportable list
B99 Other infectious diseases (Human papillomavirus, Retrovirus-HTLV types I, II, 2)
D10._ – D31._,
D34, D35.0,
D35.1, D35.5 – D35.9,
D36._
Benign neoplasms (see “must collect” list for reportable benign neoplasms)
Note: Screen for incorrectly coded malignancies or reportable by agreement tumors
Note: Borderline cystadenomas M-8442, 8451, 8462, 8472, 8473, of the ovaries moved from behavior /3 (malignant) to /1 (borderline malignancy) in ICD-O-3. SEER registries are not required to collect these cases for diagnoses made 1/1/2001 and after. However, cases diagnosed prior to 1/1/2001 should still be abstracted and reported to SEER.
D37._ – D41._ Neoplasms of uncertain or unknown behavior (see “must collect” list for reportable neoplasms of uncertain or unknown behavior)
Note: Screen for incorrectly coded malignancies or reportable by agreement tumors
D44.0 – D44.2,
D44.6 – D44.9
Neoplasm of uncertain or unknown behavior of other endocrine glands (see “must collect” list for D44.3-D44.5)
Note: Screen for incorrectly coded malignancies or reportable by agreement tumors
D47.0 Histiocytic and mast cell tumors of uncertain behavior
D47.2 Monoclonal gammopathy
Note: Screen for incorrectly coded Waldenstrom’s macroglobulinemia
D48._ Neoplasms of uncertain or unknown behavior
Note: Screen for incorrectly coded malignancies or reportable by agreement tumors
D61.8 Other specified aplastic anemias (drug induced pancytopenia)
D64.8 Other specified anemias
Note: Includes anemia due to neoplastic disease or antineoplastic chemotherapy
D69.4 – D69.6 Other thrombocytopenia
Note: Screen for incorrectly coded thrombocythemia
D70 Agranulocytosis (Note: Screen for blood disorders due to neoplasm)
D72.1 Eosinophilia (Note: Code for eosinophilia (9964/3). Not every case of eosinophilia is with a malignancy. Diagnosis must be “Hypereosonophilic syndrome” to be reportable.)
D76._ Certain diseases involving lymphoreticular tissue and reticulohistiocytic system
D89.0, D89.1 Hypergammaglobulinemia & Cryoglobulinemia
E34.0 Carcinoid syndrome
E83.5 Disorders of calcium metabolism (hypercalcemia)
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
Note: Screen for incorrectly coded Waldenstrom’s macroglobulinemia
E88.8 Other specified metabolic disorders (Tumor lysis syndrome)
K22.8 Other specified diseases of esophagus (high grade dysplasia of esophagus)
K62.8 Other specified diseases of anus and rectum (AIN I, AIN II)
K92.8 Other specified diseases of digestive system (mucositis due to cancer therapy)
N42.9 Disorder of prostate (PIN I and PIN II)
N87._ Dysplasia of cervix (CIN I and CIN II)
N89.0-N89.3 Dysplasia of vagina (VAIN I and VAIN II)
O01._ Hydatidiform mole (Note: benign tumor that can become malignant. If malignant, it should be reported as Choriocarcinoma (9100/3) with malignancy code in c00-c97))
Q85.0 Neurofibromatosis (nonmalignant) (9540/1) (Note: Neurofibromatosis by itself is not reportable, but it can lead to a reportable condition)
R18 Ascites (malignant)
R52.9 Pain, unspecified (neoplasm related pain, cancer associated pain)
R53 Malaise and fatigue (neoplasm related fatigue)
R59._ Enlarged lymph nodes
R85.6 Abnormal findings on cytological/histological exam of digestive organs
R87.6 Abnormal findings on cytological/histological exam of female genital organs
R92 Abnormal findings on diagnostic imaging of breast
Y42.1 Other and unspecified hormone antagonists (poisoning)
Y42.6 Adverse reaction to antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified
Y43.1 – Y43.4 Adverse effects in therapeutic use, antineoplastic products or drugs
Y43.9 Adverse effects in therapeutic use, primarily systemic agent, unspecified
Note: Includes poisoning by primarily systemic and hematological agents
Y63.2 Failure in dosage, overdose of radiation given during therapy
Note: Includes adverse reaction to radiation
Y84.2 Abnormal reaction, radiological procedure and radiotherapy (radiation sickness)
Y84.9 Other medical procedures (abnormal reactions, complications from central venous catheters)

Return to top